Kagayaki School's 12th Year: Empowering Adolescents with Health Education The 2025 Kagayaki School project marks its 12th year, expanding health education for adolescents from diverse backgrounds in Japan.

Kagayaki School's 12th Year: Empowering Adolescents with Health Education #Japan #Tokyo #Health_Education #Bayer_Pharmaceuticals #Kagayaki_School

Lung Cancer Research Foundation and Bayer Announce New Research Award Recipients The Lung Cancer Research Foundation, in collaboration with Bayer, has announced two research grants focusing on HER2 mutations. These grants aim to advance treatment strategies for lung cancer.

Lung Cancer Research Foundation and Bayer Announce New Research Award Recipients #USA #New_York #Bayer_Pharmaceuticals #HER2_Mutations #Lung_Cancer_Research_Foundation

Bayer Pharmaceuticals Hosts Symposium at the 70th Japanese Society for Reproductive Medicine Conference Bayer's Elevit prenatal supplement brand co-hosted a symposium on maternal and child health at the Japanese Society for Reproductive Medicine, highlighting the importance of nutrition.

Bayer Pharmaceuticals Hosts Symposium at the 70th Japanese Society for Reproductive Medicine Conference #Bayer_Pharmaceuticals #Elevit #prenatal_supplement

Bayer Pharmaceuticals Launches New WEB Commercial for Elevit® Prenatal Supplement Bayer Pharmaceuticals has begun streaming a new WEB commercial for their top-recommended prenatal supplement, Elevit®, emphasizing maternal health.

Bayer Pharmaceuticals Launches New WEB Commercial for Elevit® Prenatal Supplement #Japan #Osaka #Bayer_Pharmaceuticals #prenatal_care #Elevit®

Lung Cancer Research Foundation and Bayer Launch New Grant Initiative to Combat HER2 Mutations The Lung Cancer Research Foundation, in partnership with Bayer, has announced a $500,000 grant to support innovative research on lung cancers with HER2 mutations, addressing critical knowledge gaps and therapeutic needs.

Lung Cancer Research Foundation and Bayer Launch New Grant Initiative to Combat HER2 Mutations #United_States #New_York #Lung_Cancer_Research #Bayer_Pharmaceuticals #HER2_Mutations